To assess whether alterations in MLKs correlated with resistance to RAF inhibitor therapy, we analysed mRNA expression of MLK1–4 from the data set recently published by Rizos et al.30 The authors performed gene expression analysis on matched pretreatment and disease progression biopsies from 21 metastatic melanoma patients30. This evidence concerns the gene MAP3K9 and metastatic melanoma.